X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Trails Edge Capital Partners, LP reported a 9.90% stake in X4 Pharmaceuticals, Inc. (Schedule 13G)
Event Aug 11, 2025 · Filed Aug 18, 2025
Trails Edge Capital Partners, LP reported a 9.90% stake in X4 Pharmaceuticals, Inc., 2,317,153 shares, as a passive investor on Aug 11, 2025. Filed Aug 18, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 2,317,153
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 9.90% | 2,317,153 |
| Trails Edge Biotechnology Master Fund, LP | 9.90% | 2,317,153 |
| Ortav Yehudai | 9.90% | 2,317,153 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Trails Edge Capital Partners, LP
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Trails Edge Capital Partners, LP · Feb 17, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026